Werewolf Therapeutics Inc...

NASDAQ: HOWL · Real-Time Price · USD
1.34
0.02 (1.52%)
At close: Aug 15, 2025, 1:10 PM

Werewolf Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
1.89M 19.94M 16.4M n/a
Cost of Revenue
1.81M 1.76M 2.51M 735K
Gross Profit
71K 18.18M 13.89M -735K
Operating Income
-73.59M -40.5M -56.06M -50.09M
Interest Income
6.67M 7.42M 1.91M 104K
Pretax Income
-70.52M -37.37M -53.81M -49.98M
Net Income
-70.52M -37.37M -53.81M -49.77M
Selling & General & Admin
19.05M 18.67M 16.19M 14.82M
Research & Development
56.43M 41.78M 53.76M 35.27M
Other Expenses
-1.81M -1.76M n/a -735K
Operating Expenses
73.67M 58.68M 69.95M 49.35M
Interest Expense
4.66M 3.14M n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
75.48M 60.45M 72.46M 50.09M
Income Tax Expense
n/a n/a n/a -216K
Shares Outstanding (Basic)
43.33M 35.65M 28.86M 27.31M
Shares Outstanding (Diluted)
43.86M 35.65M 28.86M 27.31M
EPS (Basic)
-1.63 -1.05 -1.86 -7.39
EPS (Diluted)
-1.63 -1.05 -1.86 -7.39
EBITDA
-64.05M -32.47M -51.3M -49.25M
EBIT
-65.86M -34.23M -53.81M -49.98M
Depreciation & Amortization
1.81M 1.76M 2.51M 735K